- $3.68bn
- $3.82bn
- $1.83bn
- 85
- 39
- 49
- 59
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,899 | 1,836 | 1,917 | 1,795 | 1,833 |
Cost of Revenue | |||||
Gross Profit | 955 | 1,019 | 1,186 | 1,081 | 1,115 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 1,889 | 1,820 | 1,686 | 1,677 | 1,647 |
Operating Profit | 10 | 16 | 231 | 118 | 186 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -13 | -24 | 192 | 67 | 117 |
Provision for Income Taxes | |||||
Net Income After Taxes | -20 | 129 | 147 | 33 | 62 |
Net Income Before Extraordinary Items | |||||
Net Income | -20 | 129 | 147 | 33 | 62 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -20 | 129 | 147 | 33 | 62 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.113 | 1.24 | 1.38 | 0.349 | 0.611 |